GlobeNewswire by notified

Elanders makes major acquisition in North America and grows in E-Commerce

Share

Today Elanders acquired 80% of the shares in the American supply chain management company Bergen Shippers Corp. Bergen Shippers Corp operates under the name Bergen Logistics and is specialized in contract logistics services for the customer segment Fashion & Lifestyle. The company had net sales of MUSD 82 in 2020 and net sales for the full year 2021 are expected to be around MUSD 102. Forecasted EBITDA for the full year 2021 is around MUSD 15, excluding IFRS 16 effects. This acquisition will turn Fashion & Lifestyle into one of Elanders’ largest customer segments.

In line with Elanders strategy of investment and growth in the segment Fashion & Lifestyle, Elanders has signed a contract to acquire the American supply chain management company Bergen Shippers Corp. (Bergen Logistics or the Company). Through the acquisition of Bergen Logistics Elanders will be able to offer unique global solutions for brands active in Fashion & Lifestyle. The acquisition also means that Elanders will considerably strengthen its position on the North American market, which will in turn bolster Elanders’ offer in other customer segments.

Bergen Logistics is specialized in smaller and mid-sized brands in Fashion & Lifestyle and has developed a unique platform that enables them to manage a large number of customers in a highly profitable way. Their largest customer only represents four percent of the company’s total sales and the company has around 450 customers in all. Bergen Logistics operates primarily on the North American market (USA & Canada), but they also help their customers globally through their own unit in the Netherlands and through partners in Asia.

“I’m very impressed by the company Ron and Eli Roman have built. Putting Bergen Logistics together with our subsidiaries in Europe and Asia will make us a leading global actor in contract logistics solutions for companies in Fashion & Lifestyle, especially in E-Commerce. Fashion & Lifestyle is already the customer segment with the highest organic growth in Elanders, primarily driven by growth in E-Commerce. In the past year we’ve received quite a lot of requests from our European customers for help in establishing their companies on the North American market. As of tomorrow, we’ll be able to do just that. The acquisition of Bergen Logistics also means Elanders will broaden our customer base, which will make Elanders considerably less sensitive to ups and downs in the business cycle”, says Magnus Nilsson, President and CEO for Elanders.

Ron Roman, President and principle owner of Bergen Logistics comments on the deal saying:

“I’m really proud of how the company has grown, and the unique platform Bergen Logistics has developed over the past 20 years. Today we’re one of the leading players in contract logistics solutions for Fashion & Lifestyle brands in North America. Together with Elanders’ global network we can expand even further by offering Elanders’ customers ready-made solutions in North America. We’ll also be able to offer our existing customers global solutions, which are increasingly in demand.”

Bergen Logistics is expected to contribute positively to earnings per share already in 2022 and Elanders expects to consolidate Bergen into the Group in November 2021. The company is valued at MUSD 155 on a cash and debt free basis and initially Elanders will acquire 80 percent of the shares for MUSD 124. The initial purchase price will affect cash flow negatively in the fourth quarter 2021. Elanders also has a mandatory option to purchase the remaining shares in 2024 for a purchase price based on the company’s result in 2023. Acquisition costs are estimated to be around MSEK 12-15 and will charge the fourth quarter result.

The acquisition is conditional on the fulfillment of customary contractual terms. Closing is expected to take place within a couple of weeks. The acquisition is financed through Elanders own funds and an acquisition loan from the Group’s three main banks.

For further questions, please contact
Magnus Nilsson, President and CEO, telephone: +46 31 750 07 50
Andréas Wikner, CFO, telephone: +46 31 750 07 50


This information is information that Elanders AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out above, at 07:30 CET on 11 November 2021.

Attachment

To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.

About GlobeNewswire by notified

GlobeNewswire by notified
GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://notified.com

GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire by notified

Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire by notified

Centessa Pharmaceuticals Announces Pricing of $100 Million Public Offering of American Depositary Shares24.4.2024 03:36:40 CEST | Press release

BOSTON and LONDON, April 23, 2024 (GLOBE NEWSWIRE) -- Centessa Pharmaceuticals plc (Nasdaq: CNTA), a clinical-stage pharmaceutical company that aims to discover and develop medicines that are transformational for patients, today announced the pricing of an underwritten public offering of 10,810,810 American Depositary Shares (“ADSs”), each representing one ordinary share, at a price to the public of $9.25 per ADS. The aggregate gross proceeds to Centessa from this offering are expected to be approximately $100 million, before deducting underwriting discounts and commissions and offering expenses payable by Centessa. All ADSs sold in the offering were offered by Centessa. The offering is expected to close on or about April 26, 2024, subject to customary closing conditions. Centessa has also granted the underwriters a 30-day option to purchase up to an additional 1,621,621 ADSs at the public offering price, less underwriting discounts and commissions. Goldman Sachs, Leerink Partners, Eve

UK businesses must prioritise payment technology to build customer loyalty and stay competitive: New research from Lloyds Bank and FreedomPay24.4.2024 01:01:00 CEST | Press release

London, United Kingdom, April 23, 2024 (GLOBE NEWSWIRE) -- Less than a third (27%) of businesses are confident they offer seamless payments experiences.Almost two-thirds of businesses (59%) across Retail, Food & Beverages and Hospitality believe a good checkout experience offers the same competitive advantage as having the best products.Customer preference is the factor most likely to influence businesses’ investment in payment technologies. New research from Lloyds Bank and FreedomPay highlights the importance of UK businesses investing in new payment technology. Two-thirds (59%) of UK Retail, Food & Beverage (F&B) and Hospitality companies were found to already put payments at the heart of their customer experience strategy, reflecting the growing importance of payment options to customers. For retail-focused businesses, 59% believe that a good checkout experience is essential to building customer loyalty, with respondents believing it is as much a competitive advantage as having the

Millicom announces the re-issuance of its AGM and EGM Convening Notice23.4.2024 22:30:00 CEST | Press release

Millicom announces the re-issuance of its AGM and EGM Convening Notice Luxembourg, April 23, 2024 – Millicom today announced the re-issuance of the Convening Notice to its Annual General Meeting (“AGM”) and Extraordinary General Meeting (“EGM”) of Shareholders which will be held on May 23, 2024. The Convening Notice contains a rectified note to the AGM agenda item 20 (Share Repurchase Plan). All other items of the AGM and EGM remain unchanged. The Convening Notice is appended to this press release and available on the company’s website at: https://www.millicom.com/our-company/corporate-governance/shareholder-meetings/. AGM voting materials have been updated to reflect the rectified note. -END- For further information, please contact AGM/EGM Inquiries: Patrick Gill, Company Secretary +352 27 759 603 Maria Florencia Maiori, Senior Legal Counsel information@millicom.comPress: Sofia Corral, Director Corporate Communications press@millicom.comInvestors: Michel Morin, VP Investor Relations i

CNH announces signing of a €3.25 billion committed revolving credit facility23.4.2024 22:30:00 CEST | Press release

CNH announces signing of a €3.25 billion committed revolving credit facility Basildon, April 23, 2024 On April 19, 2024, CNH (NYSE: CNHI) signed a €3.25 billion committed revolving credit facility, intended for general corporate purposes of the Company. The facility, entered into with a group of 18 banks providing aggregate commitments in excess of €3.5 billion, has a 5-year tenor with two extension options of one year each, exercisable on the first and second anniversary of the signing date. It replaces an existing 5-year €4 billion facility due to mature in March 2026. The final size of the facility, set at €3.25 billion, aligns with reduced funding needs following the demerger of Iveco Group. The transaction confirms the strong support of a large panel of international key relationship banks for the Company. CNH Industrial (NYSE: CNHI) is a world-class equipment and services company. Driven by its purpose of Breaking New Ground, which centers on Innovation, Sustainability and Produc

Centessa Pharmaceuticals Announces $100 Million Proposed Public Offering of American Depositary Shares23.4.2024 22:17:37 CEST | Press release

BOSTON and LONDON, April 23, 2024 (GLOBE NEWSWIRE) -- Centessa Pharmaceuticals plc (Nasdaq: CNTA), a clinical-stage pharmaceutical company that aims to discover and develop medicines that are transformational for patients, today announced that it has commenced an underwritten public offering of $100 million of American Depositary Shares (“ADSs”), each representing one ordinary share. All of the ADSs are being offered by Centessa. In addition, Centessa intends to grant the underwriters a 30-day option to purchase up to an additional $15 million of ADSs offered in the public offering. The proposed offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering. Goldman Sachs and Leerink Partners are acting as lead joint book-running managers for the proposed offering. Evercore ISI, Guggenheim Securities and BMO Capital Markets are also acting as joint book-running mana

HiddenA line styled icon from Orion Icon Library.Eye